Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Melatonin helps hair growth in women with hair loss.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Black wolfberry ferment may help regrow hair in cases of androgenetic alopecia.

Hair loss in men is common, treatable, but not curable.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Organotypic culture systems can grow skin tissues that mimic real skin functions and are useful for skin disease and hair growth research, but they don't fully replicate skin complexity.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Hormones and genes affect hair growth and male baldness.

Antiandrogen therapy helps treat genetic hair loss.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

MC4R gene variants not linked to female hair loss.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Experts agree on understanding hair aging to improve diagnosis and treatments.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.